Chief Executive Officer
CurrentSynova is bringing technologies to market that fuel the growth of personalized regenerative medicine. We are currently in development of a device that extracts a patient's own stem cells from their fat (adipose tissue), using a novel, non-enzymatic process to provide patients, doctors and researchers with fast, safe, sterile, high-yield access to stem.